-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide: From the country to the local, drug price adjustment has been included in the overall consideration of the three or even four medical linkage, the price decline is inevitable.
2012, there has been a lot of talk in the industry about wolves coming.
When article No. 7 of 2015 came, there was a burst of tension in the industry, but the facts proved once again that the real test for enterprises is the formation of the Health Insurance Bureau, the opening of the 2018 national volume procurement, as well as the country's clear positioning of drug belt procurement - drug prices to come down, drug prices as a breakthrough to deepen medical reform.
drug prices as a breakthrough in deepening health care reform, which was not mentioned last year.
In 2016, at the executive meeting of the State Council, it was made clear that drug prices should be used as a breakthrough, drug prices should be reduced, and the performance pay system of medical institutions should be improved, thus forcing the reform of public hospitals and the reform of the drug circulation system mechanism, and promoting the reform of the medical and health system to develop in depth.
from 2016 to 2019, up and down, give enough time for production and operation enterprises, so that enterprises to transition, to adjust, to think about the sustainability of enterprise development.
not long ago, 500 drug procurement catalog out, many drug agents are uproar, calling around to consult, anxiety, confusion, pain accompanied by disappointment with the industry, everywhere, a sad.
as a price reduction storm agents, how should adjust the mentality, how to deal with? The author believes that agents should understand the following trends: First, health insurance fee control is not a constant bullet, the new situation of dual-cycle economy parallel background, pharmaceutical industry practitioners should understand the overall trend of the pharmaceutical industry, that is, in the adjustment to seek steady development.
therefore, the era of high-haired medicine is gone, hard work can win vitality, which has become the industry consensus.
, focus on monitoring drug use behavior, strict control of drug use structure has become the norm.
the past abuse of prescriptions will be greatly curbed, "scientific and rational drug use, return to the value of the product" of the new situation has been formed.
Take the national medical catalogue as an example, according to rough statistics, its own small number of Chinese medicine injections which are limited to varying degrees are not in the minority, restricted varieties, there are limited use of the scope, limited adaptive and severe patients, and the limited varieties of the general market volume is larger.
In this context, Fujian, Guangdong, Zhejiang, Anhui and other provinces and cities have developed a key drug control policy for high dosage, high prices, complementary therapeutic drugs, locked in unreasonable drug use behavior, regulating the drug use structure of medical institutions.
, public hospital medical expenses control.
establishment of the Medical Security Bureau, I believe that the drug pricing, medical insurance catalog formulation, drug tender procurement and other matters will be unified and coordinated management.
the same time, the field of medical insurance fee control is vigorously promoting the payment by disease, DRGs and other new ways of controlling fees, public hospital medical costs control, will be greatly improved.
, the adjustment of the standard of medical insurance payment.
Although the current national health insurance payment standards related policies have not been substantively introduced, but the relevant supporting policies are gradually from the "anti-cancer drug price reduction," "generic consistency evaluation of special procurement negotiations," "three batches of national volume procurement" perspective, from this point of view, in the current transition period, medical institutions in the balance of retention benefits to stimulate the background, is fully prying the medical insurance payment standard leverage, in order to volume exchange, the incentive to kill the price will not be reduced.
essence, for pharmaceutical agents, the way forward is a simple truth, to compliance, true compliance, is the return of the drug itself.
past, present and future, the return to the true value of medicine is the future of medicine people to stand the root, and work together.
.